A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease

Neurology. 1998 May;50(5):1458-61. doi: 10.1212/wnl.50.5.1458.

Abstract

In a population-based case-control study, we found a reversal of the association of cigarette smoking with Parkinson's disease (PD) in relation to the monoamine oxidase B intron 13 genetic polymorphism. A reduced PD risk related to pack-years of smoking was detected for persons with the G allele, whereas an opposite effect was found among persons with the A allele. These results indicate an unexplained interaction between cigarette smoking and this genetic polymorphism.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Case-Control Studies
  • Female
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Monoamine Oxidase / genetics*
  • Parkinson Disease / etiology*
  • Parkinson Disease / genetics
  • Polymorphism, Genetic*
  • Risk Factors
  • Smoking / adverse effects*

Substances

  • Monoamine Oxidase